天然产物研究与开发 ›› 2022, Vol. 34 ›› Issue (11): 1822-1831.doi: 10.16333/j.1001-6880.2022.11.002

• 研究论文 • 上一篇    下一篇

黄连半夏药对治疗慢性萎缩性胃炎作用机制研究

向   阳1,黄   琼3*,袁   林23   

  1. 1云南中医药大学,昆明 650000;2风湿性疾病发生与干预湖北省重点实验室;3 湖北民族大学,恩施 445000
  • 出版日期:2022-11-25 发布日期:2022-11-25
  • 基金资助:
    风湿性疾病发生与干预湖北省重点实验室第四批开放基金(OIR19009A);云南省王庆国专家工作站(202005AF150017)

Study on the mechanism of Coptidis Rhizoma and Pinelliae Rhizoma in treating chronic atrophic gastritis

XIANG Yang1,HUANG Qiong3*,YUAN Lin23   

  1. 1Yunnan University of Chinese Medicine,Kunming 650000,China; 2 Hubei Provincial Key Laboratory of Occurrence and Intervention of Rheumatic Diseases; 3 Hubei Minzu University,Enshi 445000,China
  • Online:2022-11-25 Published:2022-11-25

摘要:

本研究基于分子对接与动物实验探讨黄连半夏药对治疗慢性萎缩性胃炎的作用机理。首先,在TCMSP数据库中筛选黄连半夏主要成分,利用vina软件与IL-1β、IL-6、YAP1、STAT3、JAK2、VEGF、EGFR进行分子对接;其次,采用复合方法建立大鼠模型,随机分为模型(B)组,维酶素(C)组,低、中、高剂量(D、E、F)组,每组10只。造模成功后,D、E、F组采用黄连半夏水煎液(1∶2∶4)灌胃,B、C组分别予生理盐水(1 mL/100 g)、维酶素(0.3 g/kg)灌胃,连续8周。治疗结束后,获取大鼠血液与胃组织样本,采用ELISA检测血清IL-1β、IL-6含量,HE染色观察胃组织形态,RT-PCR检测胃组织中JAK2、STAT3、AKT1、YAP1、VEGF、EGFR mRNA的表达,Western blot测胃组织p-STAT3、p-JAK2、p-AKT、p-YAP1水平。实验结果发现:黄连半夏所含主要活性成分均能与关键靶标结合;各治疗组能有效修复胃黏膜形态、减少炎症及肠化生,且E组优于其他各组;E、F组血清IL-6、IL-1β含量、胃组织中JAK2、STAT3、AKT1、YAP1、VEGF、EGFR mRNA表达量及p-STAT3、p-JAK2、p-AKT1水平均较B、C组显著降低(P<0.01)。但在p-YAP1水平上各治疗组均较B组显著上升(P<0.01)且E组优于其他各组。实验结果表明黄连半夏所含主要成分可通过降低慢性萎缩性胃炎大鼠血清炎症因子水平,抑制JAK2/STAT3通路与血管新生途径,修复胃黏膜形态,防止其向恶性肿瘤演化。

关键词: 黄连, 半夏, 慢性萎缩性胃炎, 药对, 机制

Abstract:

This study is based on molecular docking and animal experiments to investigate the mechanism of Coptidis Rhizoma and Pinelliae Rhizoma in the treatment of chronic atrophic gastritis.First,the main components of Coptidis Rhizoma and Pinelliae Rhizoma were screened in the TCMSP database,and molecular docking was carried out with IL-1β,IL-6,YAP1,STAT3,JAK2,VEGF,and EGFR using vina software; Secondly,a compound method was used to establish a rat model,and the rats were randomly divided into model (B) group,vitrein (C) group,and low-,medium- and high-dose (D,E,F) groups,with 10 rats in each group.After successful modeling,groups D,E,and F were given HL and BX decoction (1∶2∶4) by gavage,respectively,and groups B and C were given NaCl (1 mL/100 g) and vermin,respectively.Groups were treated for a total of 8 weeks.After the treatment,the blood and gastric tissue samples of the rats were obtained,serum IL-1β and IL-6 levels were detected by ELISA.HE staining was used to observe the morphology of gastric tissue.RT-PCR detection of JAK2 mRNA,STAT3 mRNA,AKT1 mRNA,YAP1 mRNA,VEGF mRNA,EGFR mRNA expression in gastric tissue,the levels of p-STAT3,p-JAK2,p-AKT and p-YAP1 in gastric tissue were detected by WB.The experimental results found that the main active components of Coptidis Rhizoma and Pinelliae Rhizoma can bind to key targets; Each treatment group can effectively repair gastric mucosa morphology,reduce inflammation and intestinal metaplasia,and group E is better than other groups; The serum levels of IL-6 and IL-1β,the levels of JAK2 mRNA,STAT3 mRNA,AKT1 mRNA,YAP1 mRNA,VEGF mRNA,EGFR mRNA and the levels of p-STAT3,p-JAK2,and p-AKT1 in groups E and F were all in gastric tissue.It was significantly lower than that of group B and C (P<0.01).However,the level of p-YAP1 in each treatment group was significantly higher than that in group B (P<0.01),and group E was better than other groups.The experimental results show that the main components of Coptidis Rhizoma and Pinelliae Rhizoma can restore the morphology of gastric mucosa and prevent the evolution of malignant tumors by reducing the level of serum inflammatory factors in rats with chronic atrophic gastritis,inhibiting the JAK2/STAT3 pathway and angiogenesis pathway.

Key words: Coptidis Rhizoma, Pinelliae Rhizoma, chronic atrophic gastritis, drug pair, mechanism

中图分类号:  R285.5